Clinical Trial Update: Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing intravitreal bevacizumab with photocoagulation for proliferative diabetic retinopathy has been withdrawn (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetic Retinopathy | Phase 2, Phase 3 | Status: WITHDRAWN